Japan · Delayed Price · Currency is JPY Meiji Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Operating profit exceeded plan in FY 2025, driven by pharmaceuticals, while food segment lagged due to cost pressures and China impairment. FY 2026 targets higher profits through structural reforms, global expansion, and disciplined capital allocation, with ROE and ROIC improvement as key goals.
-
First half operating profit exceeded plan despite lower net sales and profit year-on-year, with strong pharmaceuticals and resilient food segments. Full-year sales guidance was revised down, but profit forecasts remain unchanged amid ongoing structural reforms and cost pressures.
Fiscal Year 2025
-
First-half net sales rose 4.2% year-on-year, with operating profit flat and profit attributable to owners down 3.8% due to lower extraordinary gains. Food segment faced cost pressures but expects recovery via price hikes, while pharma segment saw strong first half but faces lower second-half profit from reduced COVID vaccine demand.